Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.

@article{Mcclung2006PreventionOB,
  title={Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.},
  author={Michael R Mcclung and Ethel S. Siris and Steve Cummings and Michael Bolognese and Mark Ettinger and Alfred H Moffett and Ronald D Emkey and Wesley W. Day and Veena R Somayaji and Andrew Lee},
  journal={Menopause},
  year={2006},
  volume={13 3},
  pages={377-86}
}
OBJECTIVE Osteoporosis is a significant health problem in postmenopausal women. Consequently, new and effective therapies are being sought to preserve bone mass and prevent osteoporosis in this population of women. The objective of this study was to compare the effects of lasofoxifene with raloxifene and placebo on indices of bone health in postmenopausal women. DESIGN A randomized, double-blind, placebo- and active treatment-controlled study of 2 years duration was conducted. Women included… CONTINUE READING